
Sign up to save your podcasts
Or


Marty talks about a new enterprise study that will use the AVP as a means for collecting EEG waves from people with neurological disorders, allowing them to communicate through the device.
“This Startup Wants to Put Its Brain-Computer Interface in the Apple Vision Pro” – Wiredhttps://www.wired.com/story/this-startup-wants-to-put-its-brain-computer-interface-in-the-apple-vision-pro/
Key Points
1. Who Cognixion is
- A California-based startup focused on non-invasive BCIs (EEG-based), avoiding surgical implants.
- Its mission is to enable communication for people with ALS, paralysis, and other conditions that limit speech.
- Previously built the dedicated Axon-R headset, tested with ALS patients.
2. Vision Pro Integration
- Cognixion is preparing a clinical trial with ~10 participants using a Vision Pro modified with their custom EEG headband.
- The system detects visual fixation and attention patterns so users can select items on-screen by focusing on them.
- A neural-computing pack worn at the hip processes the brain-signal data.
3. Role of AI
- Cognixion uses per-user generative-AI models trained on the user’s prior communication to predict words or phrases.
- In Axon-R trials, participants reached near-conversational communication speeds during multi-hour weekly sessions.
4. Opportunities & Challenges
Advantages:
- Non-invasive → less risk, potentially faster adoption.- Leverages a mainstream headset (Vision Pro) and its spatial-computing ecosystem.
- AI support can help overcome the low signal resolution of non-invasive EEG.
Challenges:
- EEG remains less precise than implanted BCIs, so decoding speed and reliability must improve.
- The hardware still involves extra components (headband, hip pack) and must be ergonomic and socially acceptable.
- Regulatory hurdles: moving from small clinical trial to FDA-approved assistive-tech product.
We’ll revisit this topic in an upcoming Vision ProFiles episode with more expert insights and discussion.
Remember to follow the live stream at YouTube.com/@VisionProfiles on Monday nights at 9 PM EST, or catch the recording later on YouTube, or subscribe to the audio version on your favorite podcast platform.
Email: [email protected]
Website: ThePodTalk.Net
YouTube: YouTube.com/@VisionProFiles
By Marty Jencius and Eric Bolden4.5
1616 ratings
Marty talks about a new enterprise study that will use the AVP as a means for collecting EEG waves from people with neurological disorders, allowing them to communicate through the device.
“This Startup Wants to Put Its Brain-Computer Interface in the Apple Vision Pro” – Wiredhttps://www.wired.com/story/this-startup-wants-to-put-its-brain-computer-interface-in-the-apple-vision-pro/
Key Points
1. Who Cognixion is
- A California-based startup focused on non-invasive BCIs (EEG-based), avoiding surgical implants.
- Its mission is to enable communication for people with ALS, paralysis, and other conditions that limit speech.
- Previously built the dedicated Axon-R headset, tested with ALS patients.
2. Vision Pro Integration
- Cognixion is preparing a clinical trial with ~10 participants using a Vision Pro modified with their custom EEG headband.
- The system detects visual fixation and attention patterns so users can select items on-screen by focusing on them.
- A neural-computing pack worn at the hip processes the brain-signal data.
3. Role of AI
- Cognixion uses per-user generative-AI models trained on the user’s prior communication to predict words or phrases.
- In Axon-R trials, participants reached near-conversational communication speeds during multi-hour weekly sessions.
4. Opportunities & Challenges
Advantages:
- Non-invasive → less risk, potentially faster adoption.- Leverages a mainstream headset (Vision Pro) and its spatial-computing ecosystem.
- AI support can help overcome the low signal resolution of non-invasive EEG.
Challenges:
- EEG remains less precise than implanted BCIs, so decoding speed and reliability must improve.
- The hardware still involves extra components (headband, hip pack) and must be ergonomic and socially acceptable.
- Regulatory hurdles: moving from small clinical trial to FDA-approved assistive-tech product.
We’ll revisit this topic in an upcoming Vision ProFiles episode with more expert insights and discussion.
Remember to follow the live stream at YouTube.com/@VisionProfiles on Monday nights at 9 PM EST, or catch the recording later on YouTube, or subscribe to the audio version on your favorite podcast platform.
Email: [email protected]
Website: ThePodTalk.Net
YouTube: YouTube.com/@VisionProFiles

827 Listeners

310 Listeners

211 Listeners

1,288 Listeners

3,131 Listeners

2,127 Listeners

972 Listeners

568 Listeners

722 Listeners

1,210 Listeners

508 Listeners

496 Listeners

5,472 Listeners

237 Listeners

21 Listeners